Three LMU researchers elected to Leopoldina

Frederick Klauschen, Director of LMU’s Institute of Pathology, has been elected to the Pathology and Forensic Medicine section of the Leopoldina. Klauschen’s main research interests lie in the domains of AI in medicine and the integration of histological and proteogenomic imaging techniques in cancer research. His goal is to better understand and predict pathological mechanisms in tumors with a view to better understanding and treating conditions such as cancer.

Claudia Bausewein, Chair of Palliative Medicine at LMU, has been elected to the Global Health section of the academy of sciences. Bausewein is Director of the Clinic and Polyclinic for Palliative Medicine at LMU University Hospital. Her research interests include complexity in palliative care, shortness of breath in patients with advanced conditions, sedation at end of life, and drug therapy in palliative care.

Markus M. Lerch, Medical Director and Chairman of the Board of LMU University Hospital, has been elected to the Internal Medicine and Dermatology section of the academy. Before coming to Munich, the specialist in internal medicine, gastroenterology, endocrinology, and biochemistry was Director of Greifswald University Hospital. His main clinical and research interests are in the fields of pathophysiology, cell biology, and the genetics of diseases of the pancreas and in improving the treatment of patients with pancreatic conditions.

Founded over 360 years ago, the Leopoldina is the oldest academy of sciences in the world in continuous existence. One of its principal tasks is to provide politicians and the public with science-based advice. Another consists in representing German science on international committees. In 2008, the Leopoldina, which is headquartered today in Halle, received its current designation of German National Academy of Sciences. Most of its members come from Germany, Austria, and Switzerland.